Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Egalet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Egalet Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Egalet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Egalet Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Egalet Corp, Medical Devices Deals, 2012 to YTD 2018 10
Egalet Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Egalet Corp, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Egalet to Acquire Four Non-Narcotic Pain Products from Iroko Pharma 12
Egalet Acquires SPRIX Nasal Spray from Luitpold Pharma 14
Venture Financing 16
Egalet Raises USD15 Million in Venture Debt Financing 16
Egalet Raises US$10 Million In Initial Closing Of Venture Financing 17
Egalet Raises US$14.3 Million In Series B2 Financing 18
Egalet Secures Venture Funding 20
Partnerships 21
Egalet Enters into Co-promotion Agreement with Ascend Therapeutics 21
Egalet Enters into Agreement with Teva Pharma 22
Licensing Agreements 23
Egalet Enters into Licensing Agreement with Acura Pharma 23
Equity Offering 24
Egalet to Raise USD8.5 Million in Public Offering of Shares 24
Egalet Plans to Raise upto USD16 Million in Public Offering of Shares 25
Egalet Raises USD30 Million in Public Offering of Shares and Warrants 26
Egalet Raises USD1 Million in Public Offering of Shares 28
Egalet Raises USD0.9 Million in Public Offering of Shares 29
Egalet Raises USD86.3 Million in Public Offering of Shares 30
Egalet Completes IPO For US$58 Million 32
Egalet Completes Private Placement Of Shares For US$15 Million 34
Debt Offering 35
Egalet Raises USD40 Million in Second Tranche of Private Placement of 13% Notes 35
Egalet Raises USD40 Million in First Tranche of Private Placement of 13% Notes 36
Egalet Raises USD60 Million in Private Placement of Notes Due 2020 37
Egalet Corp – Key Competitors 38
Egalet Corp – Key Employees 39
Egalet Corp – Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Recent Developments 41
Financial Announcements 41
Aug 08, 2018: Egalet reports second quarter 2018 financial results 41
May 08, 2018: Egalet Reports First Quarter 2018 Financial Results 42
Mar 12, 2018: Egalet Reports Fourth Quarter and Full Year 2017 Financial Results 43
Nov 08, 2017: Egalet Announces Third Quarter 2017 Financial Results 44
Aug 09, 2017: Egalet Announces Second Quarter 2017 Financial Results and Expense Reduction Plan 45
May 10, 2017: Egalet Reports First Quarter 2017 Financial Results 46
Mar 09, 2017: Egalet Reports Fourth Quarter and Full Year 2016 Financial Results 48
Corporate Communications 49
Jun 07, 2018: Egalet Names John Varian Board Director 49
Apr 10, 2017: Egalet Announces Changes to Board of Directors 50
Government and Public Interest 51
Nov 20, 2017: Egalet Received a Grant from InnoBooster to Develop a Novel Application of Guardian Technology 51
Product News 52
05/15/2017: Egalet Announces Scientific Presentations at American Pain Society Meeting 52
Product Approvals 53
Apr 18, 2017: Egalet Announces U.S. Food and Drug Administration Acceptance of File for Prior Approval Supplement for OXAYDO (oxycodone HCl, USP) tablets C-II 10 mg and 15 mg Dosage Strengths 53
Clinical Trials 54
Nov 28, 2017: Egalet Announces Positive Top-Line Results from Phase 3 Study Evaluating Efficacy and Safety of Egalet-002 in Patients with Moderate-to-Severe Chronic Low Back Pain 54
Nov 16, 2017: Egalet Announces Positive Top-Line Results from Phase 3 Safety Study Evaluating Safety of Egalet-002 55
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56
Egalet Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Egalet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Egalet Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Egalet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Egalet Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Egalet Corp, Medical Devices Deals, 2012 to YTD 2018 10
Egalet Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Egalet to Acquire Four Non-Narcotic Pain Products from Iroko Pharma 12
Egalet Acquires SPRIX Nasal Spray from Luitpold Pharma 14
Egalet Raises USD15 Million in Venture Debt Financing 16
Egalet Raises US$10 Million In Initial Closing Of Venture Financing 17
Egalet Raises US$14.3 Million In Series B2 Financing 18
Egalet Secures Venture Funding 20
Egalet Enters into Co-promotion Agreement with Ascend Therapeutics 21
Egalet Enters into Agreement with Teva Pharma 22
Egalet Enters into Licensing Agreement with Acura Pharma 23
Egalet to Raise USD8.5 Million in Public Offering of Shares 24
Egalet Plans to Raise upto USD16 Million in Public Offering of Shares 25
Egalet Raises USD30 Million in Public Offering of Shares and Warrants 26
Egalet Raises USD1 Million in Public Offering of Shares 28
Egalet Raises USD0.9 Million in Public Offering of Shares 29
Egalet Raises USD86.3 Million in Public Offering of Shares 30
Egalet Completes IPO For US$58 Million 32
Egalet Completes Private Placement Of Shares For US$15 Million 34
Egalet Raises USD40 Million in Second Tranche of Private Placement of 13% Notes 35
Egalet Raises USD40 Million in First Tranche of Private Placement of 13% Notes 36
Egalet Raises USD60 Million in Private Placement of Notes Due 2020 37
Egalet Corp, Key Competitors 38
Egalet Corp, Key Employees 39
Egalet Corp, Other Locations 40
Egalet Corp, Subsidiaries 40
List of Figures
Egalet Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Egalet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Egalet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Egalet Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Egalet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Egalet Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Egalet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Egalet Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Egalet Corp, Medical Devices Deals, 2012 to YTD 2018 10